Insider holders · CIK 0001512762
Coherus Oncology, Inc. · CHRS
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| V-Sciences Investments Pte Ltd10% Owner | 6,556,116 | — | 6,556,116 | Aug 31, 2017 · 4:15 pm EDT | Form 3 |
| Temasek Life Sciences Private Ltd10% Owner | 6,556,116 | — | 6,556,116 | Aug 31, 2017 · 4:15 pm EDT | Form 3 |
| Fullerton Management Pte Ltd10% Owner | 6,556,116 | — | 6,556,116 | Aug 31, 2017 · 4:15 pm EDT | Form 3 |
| Temasek Holdings (Private) Ltd10% Owner | 6,556,116 | — | 6,556,116 | Aug 31, 2017 · 4:15 pm EDT | Form 3 |
| James HealyDirector | 92 | 2,868,221 | 2,868,313 | Jan 30, 2019 · 4:07 pm EST | Form 4 |
| FMR LLCrelationship not stated | — | 361,594 | 361,594 | Aug 10, 2016 · 2:39 pm EDT | Form 4 |
| Alan C. HermanChief Scientific Officer | 50,460 | 300,164 | 350,624 | Dec 19, 2017 · 4:07 pm EST | Form 4 |
| August J. TroendleDirector | 29,994 | 268,428 | 298,422 | Feb 5, 2018 · 4:07 pm EST | Form 4 |
| Mats WahlstromDirector | 30,000 | 219,914 | 249,914 | Jun 9, 2026 · 6:40 pm EDT | Form 4 |
| Dennis M LanfearPresident and CEO | 125,017 | 86,965 | 211,982 | Jan 15, 2019 · 4:07 pm EST | Form 4 |
| Christos RichardsDirector | 63,836 | — | 63,836 | Jan 30, 2019 · 4:05 pm EST | Form 4 |
| Barbara K FinckChief Medical Officer | 37,043 | — | 37,043 | Sep 12, 2018 · 4:05 pm EDT | Form 4 |
| Michael Lee RyanDirector | 30,000 | — | 30,000 | Jun 9, 2026 · 6:41 pm EDT | Form 4 |
| Jill O'Donnell-TormeyDirector | 30,000 | — | 30,000 | Jun 9, 2026 · 6:41 pm EDT | Form 4 |
| Charles W. NewtonDirector | 30,000 | — | 30,000 | Jun 9, 2026 · 6:39 pm EDT | Form 4 |
| Lee Nisley NewcomerDirector | 30,000 | — | 30,000 | Jun 9, 2026 · 6:42 pm EDT | Form 4 |
| Ali J. SatvatDirector | 30,000 | — | 30,000 | Jun 9, 2026 · 9:57 pm EDT | Form 4 |
| Rita A KarachunDirector | 30,000 | — | 30,000 | Jun 9, 2026 · 6:43 pm EDT | Form 4 |
| Vladimir VexlerChief Scientific Officer | 17,474 | — | 17,474 | Jan 15, 2019 · 4:05 pm EST | Form 4 |
| Vincent R AnicettiChief Operating Officer | 17,295 | — | 17,295 | Jan 15, 2019 · 4:05 pm EST | Form 4 |
| Jean-Frederic ViretChief Financial Officer | 16,185 | — | 16,185 | Jan 15, 2019 · 4:06 pm EST | Form 4 |
| Peter K. WatlerChief Technical Officer | 5,900 | 0 | 5,900 | Feb 5, 2018 · 4:07 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.